Skip to content
Checking whether you are signed in

NuScale Power Corporation

SMRNew York Stock ExchangeFull coverage

Price
Loading your watchlists

Latest dossier

AI-generated

General research and analysis by Moatsight, not personalized investment advice. We show, you decide. Disclaimers

How dossiers are written

Q3 of fiscal year 2026 · Published Nov 10, 2026, 3:55 AM UTC

NuScale Power designs a small modular nuclear reactor that has the only design approval from the US Nuclear Regulatory Commission, but it has not yet sold a module, and revenue fell to $0.3 million in the third quarter of 2026 as earlier engineering work ended. Its main prospect, a plan by its exclusive sales partner ENTRA1 Energy for up to 72 modules at the Tennessee Valley Authority, is still non-binding, and management gave no date for a binding agreement after missing every customer date it has set since 2023. Under its agreement with ENTRA1, NuScale has already paid $507.4 million and owes about $45.8 million per module at 2025 prices as orders advance, rising at least 5% a year, which on our estimates takes most of the gross profit on each module. Moatsight estimates free cash flow of about −$421 million over the next four quarters, as a first binding agreement would trigger a further payment to ENTRA1 of about $212 million.

Read the dossier

What you pay

FigureAt the close5-yr median5-yr range
P/ENo value: no close yetNo value: no price history
EV/SalesNo value: no close yetNo value: no price history
EV/EBITDANo value: no close yetNo value: no price history
Price/FCFNo value: no close yetNo value: no price history
Market capNo value: no close yet
Net debt and other claims(enterprise value minus market cap)No value: no close yet
Enterprise valueNo value: no close yet

How the business is doing

FigureLast 12 months1-year change1-yearYearly, 3 years8 quarters
Revenue$2.7M−95.7%(worse for the company)−49.9%Each quarter is listed in the row's details.
Diluted EPS−$0.45n/m, not meaningful: from zero or belowNo value: splits not confirmedEach quarter is listed in the row's details.
Free cash flow−$607.5MNo value: cannot be derivedn/m, not meaningful: from zero or belowEach quarter is listed in the row's details.
Gross margin−2.2%−68.9 pp(worse for the company)−6.8 ppEach quarter is listed in the row's details.
Operating margin−9,493.2%−8,509.2 pp(worse for the company)−2,746.5 ppEach quarter is listed in the row's details.
Net margin−6,817.0%−6,222.4 pp(worse for the company)−2,192.1 ppEach quarter is listed in the row's details.
Share count410.458M+177.9%(worse for the company)No value: splits not confirmedEach quarter is listed in the row's details.
How to read these figures
  • Last 12 months: the latest four reported quarters added up, or a figure computed from them. The share count is its latest quarter's average.
  • 1-year change: the last 12 months against the 12 months a year earlier. A margin's change is in percentage points (pp). On a Next 12 months row, it is Moatsight's estimate against the last 12 months.
  • Yearly, 3 years: the yearly rate over the last 3 years, compounded. For a margin, its average change a year in percentage points.
  • 8 quarters: the last 12 months at each of the latest 8 quarter ends, oldest on the left; the dot is the latest. The quarters themselves are on Financials.
  • n/m: not meaningful, such as a rate of change from a loss.
  • Color: a 1-year change in the gain color is better for the company, one in the loss color worse. The caret and the sign show which way it moved, and a row where lower is better says so in its details. Color judges the company's reported results, never its share price or Moatsight's estimates, and no other column is colored.

Price

No closing prices are stored for this listing yet.

Facts

Exchange
New York Stock Exchange · USD
Kind
Common stock
Security
Common Stock